TY - JOUR
T1 - Trends in cardiometabolic risk factors in the Americas between 1980 and 2014
T2 - A pooled analysis of population-based surveys
AU - NCD Risk Factor Collaboration (NCD-RisC) - Americas Working Group
AU - Miranda, J. Jaime
AU - Carrillo-Larco, Rodrigo M.
AU - Ferreccio, Catterina
AU - Hambleton, Ian R.
AU - Lotufo, Paulo A.
AU - Nieto-Martinez, Ramfis
AU - Zhou, Bin
AU - Bentham, James
AU - Bixby, Honor
AU - Hajifathalian, Kaveh
AU - Lu, Yuan
AU - Taddei, Cristina
AU - Abarca-Gomez, Leandra
AU - Acosta-Cazares, Benjamin
AU - Aguilar-Salinas, Carlos A.
AU - Andrade, Dolores S.
AU - Assuncao, Maria Cecilia F.
AU - Barcelo, Alberto
AU - Barros, Aluisio J.D.
AU - Barros, Mauro V.G.
AU - Bata, Iqbal
AU - Batista, Rosangela L.
AU - Benet, Mikhail
AU - Bernabe-Ortiz, Antonio
AU - Bettiol, Heloisa
AU - Boggia, Jose G.
AU - Boissonnet, Carlos P.
AU - Brewster, Lizzy M.
AU - Cameron, Christine
AU - Candido, Ana Paula C.
AU - Cardoso, Viviane C.
AU - Chan, Queenie
AU - Christofaro, Diego G.
AU - Confortin, Susana C.
AU - Craig, Cora L.
AU - D'Orsi, Eleonora
AU - Delisle, Helene
AU - De Oliveira, Paula Duarte
AU - Dias-Da-Costa, Juvenal Soares
AU - Diaz, Alejandro
AU - Donoso, Silvana P.
AU - Elliott, Paul
AU - La Pena, Jorge Escobedo De
AU - Ferguson, Trevor S.
AU - Fernandes, Romulo A.
AU - Ferrante, Daniel
AU - Flores, Eric Monterubio
AU - Francis, Damian K.
AU - Do Carmo Franco, Maria
AU - Tarqui-Mamani, Carolina B.
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2020/1
Y1 - 2020/1
N2 - Background Describing the prevalence and trends of cardiometabolic risk factors that are associated with noncommunicable diseases (NCDs) is crucial for monitoring progress, planning prevention, and providing evidence to support policy efforts. We aimed to analyse the transition in body-mass index (BMI), obesity, blood pressure, raised blood pressure, and diabetes in the Americas, between 1980 and 2014. Methods We did a pooled analysis of population-based studies with data on anthropometric measurements, biomarkers for diabetes, and blood pressure from adults aged 18 years or older. A Bayesian model was used to estimate trends in BMI, raised blood pressure (systolic blood pressure =140 mm Hg or diastolic blood pressure =90 mm Hg), and diabetes (fasting plasma glucose =7.0 mmol/L, history of diabetes, or diabetes treatment) from 1980 to 2014, in 37 countries and six subregions of the Americas. Findings 389 population-based surveys from the Americas were available. Comparing prevalence estimates from 2014 with those of 1980, in the non-English speaking Caribbean subregion, the prevalence of obesity increased from 3.9% (95% CI 2.2-6.3) in 1980, to 18.6% (14.3-23.3) in 2014, in men; and from 12.2% (8.2-17.0) in 1980, to 30.5% (25.7-35.5) in 2014, in women. The English-speaking Caribbean subregion had the largest increase in the prevalence of diabetes, from 5.2% (2.1-10.4) in men and 6.4% (2.6-10.4) in women in 1980, to 11.1% (6.4-17.3) in men and 13.6% (8.2-21.0) in women in 2014). Conversely, the prevalence of raised blood pressure has decreased in all subregions; the largest decrease was found in North America from 27.6% (22.3-33.2) in men and 19.9% (15.8-24.4) in women in 1980, to 15.5% (11.1-20.9) in men and 10.7% (7.7-14.5) in women in 2014. Interpretation Despite the generally high prevalence of cardiometabolic risk factors across the Americas, estimates also showed a high level of heterogeneity in the transition between countries. The increasing prevalence of obesity and diabetes observed over time requires appropriate measures to deal with these public health challenges. Our results support a diversification of health interventions across subregions and countries.
AB - Background Describing the prevalence and trends of cardiometabolic risk factors that are associated with noncommunicable diseases (NCDs) is crucial for monitoring progress, planning prevention, and providing evidence to support policy efforts. We aimed to analyse the transition in body-mass index (BMI), obesity, blood pressure, raised blood pressure, and diabetes in the Americas, between 1980 and 2014. Methods We did a pooled analysis of population-based studies with data on anthropometric measurements, biomarkers for diabetes, and blood pressure from adults aged 18 years or older. A Bayesian model was used to estimate trends in BMI, raised blood pressure (systolic blood pressure =140 mm Hg or diastolic blood pressure =90 mm Hg), and diabetes (fasting plasma glucose =7.0 mmol/L, history of diabetes, or diabetes treatment) from 1980 to 2014, in 37 countries and six subregions of the Americas. Findings 389 population-based surveys from the Americas were available. Comparing prevalence estimates from 2014 with those of 1980, in the non-English speaking Caribbean subregion, the prevalence of obesity increased from 3.9% (95% CI 2.2-6.3) in 1980, to 18.6% (14.3-23.3) in 2014, in men; and from 12.2% (8.2-17.0) in 1980, to 30.5% (25.7-35.5) in 2014, in women. The English-speaking Caribbean subregion had the largest increase in the prevalence of diabetes, from 5.2% (2.1-10.4) in men and 6.4% (2.6-10.4) in women in 1980, to 11.1% (6.4-17.3) in men and 13.6% (8.2-21.0) in women in 2014). Conversely, the prevalence of raised blood pressure has decreased in all subregions; the largest decrease was found in North America from 27.6% (22.3-33.2) in men and 19.9% (15.8-24.4) in women in 1980, to 15.5% (11.1-20.9) in men and 10.7% (7.7-14.5) in women in 2014. Interpretation Despite the generally high prevalence of cardiometabolic risk factors across the Americas, estimates also showed a high level of heterogeneity in the transition between countries. The increasing prevalence of obesity and diabetes observed over time requires appropriate measures to deal with these public health challenges. Our results support a diversification of health interventions across subregions and countries.
UR - http://www.scopus.com/inward/record.url?scp=85076249150&partnerID=8YFLogxK
U2 - 10.1016/S2214-109X(19)30484-X
DO - 10.1016/S2214-109X(19)30484-X
M3 - Artículo
C2 - 31839128
AN - SCOPUS:85076249150
SN - 2214-109X
VL - 8
SP - e123-e133
JO - The Lancet Global Health
JF - The Lancet Global Health
IS - 1
ER -